ConductScience.org, home

Paper7284966

Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics.

Van Der Esch EP and 4 others. Cancer, 1981. Cited by 123 papers, by iCite.

Cite this record

ConductScience Library. Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Papers, record 7284966. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7284966

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics.
PubMed
Journal
Cancer
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
6.08
iCite
Revised in PubMed
2019-06-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Der Esch EPE P
2Cascinelli NN
3Preda FF
4Morabito AA
5Bufalino RR

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adult
Female
Humans
Male
Middle Aged
Mitosis
Neoplasm Staging
Prognosis
Skin Ulcer

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
38626072Could the mitotic count improve personalized prognosis in melanoma patients?PLoS One2024https://conductscience.org/library/papers/38626072PubMed
30190817Follow-up in patients with low-risk cutaneous melanoma: is it worth it?Melanoma Manag2014https://conductscience.org/library/papers/30190817PubMed
28445515Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.PLoS One2017https://conductscience.org/library/papers/28445515PubMed
21111956Staging and prognosis of cutaneous melanoma.Surg Oncol Clin N Am2011https://conductscience.org/library/papers/21111956PubMed
20379784Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.Ann Surg Oncol2010https://conductscience.org/library/papers/20379784PubMed
20183437Parametric modeling of localized melanoma prognosis and outcome.J Biopharm Stat2009https://conductscience.org/library/papers/20183437PubMed
12556972Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.Br J Cancer2003https://conductscience.org/library/papers/12556972PubMed
11002760ACP best practice no 162. The histological reporting of melanoma. Association of Clinical Pathologists.J Clin Pathol2000https://conductscience.org/library/papers/11002760PubMed
8611411Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.Br J Cancer1996https://conductscience.org/library/papers/8611411PubMed
7730486Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma.J Clin Pathol1995https://conductscience.org/library/papers/7730486PubMed
7684198Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA).Am J Pathol1993https://conductscience.org/library/papers/7684198PubMed
7149819A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.Ann Surg1982https://conductscience.org/library/papers/7149819PubMed
6699074The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6699074PubMed
6476888Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.Arch Dermatol Res1984https://conductscience.org/library/papers/6476888PubMed
6415909Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases.Virchows Arch A Pathol Anat Histopathol1983https://conductscience.org/library/papers/6415909PubMed
6363458Measuring melanomas: the Vernier method.J Clin Pathol1984https://conductscience.org/library/papers/6363458PubMed
3977452Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.Ann Surg1985https://conductscience.org/library/papers/3977452PubMed
3936264Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.Virchows Arch A Pathol Anat Histopathol1985https://conductscience.org/library/papers/3936264PubMed
3923697Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.Virchows Arch A Pathol Anat Histopathol1985https://conductscience.org/library/papers/3923697PubMed
3355269Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.Ann Surg1988https://conductscience.org/library/papers/3355269PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7284966

GET https://conductscience.org/api/papers/v1/7284966/cited_by?page=2